Remote Ischemic Conditioning in Abdominal Surgery

Not Applicable

• Conditions: Pancreatic Diseases; Gastrointestinal Disease; Laparotomy; Laparoscopy; Retroperitoneal Disease; Pelvis Disease; Liver Diseases; Complication of Surgical Procedure; Urologic Diseases
• Interventions: Procedure: No Remote ischemic conditioning; Procedure: Remote ischemic conditioning

• Registration Number: NCT03234543
• Lead Sponsor: Rutgers, The State University of New Jersey

Brief Summary

This phase II randomized (1:1) controlled trial will examine the effects of remote ischemic conditioning (RIC) on the outcomes of major abdominal surgery. One hundred subjects will be enrolled at a single institution - University Hospital - Newark. The study population are patients undergoing major abdominal surgery (anticipated to be \>/= 2 hrs long with a hospital stay \>/= 2 days). Subjects in the treatment group will receive lower limb ischemic conditioning at 3 different time points: before surgery, POD 1 and POD 2. The primary outcome is the 30-day comprehensive complications index (CCI). Key secondary outcomes are changes in systemic inflammatory markers in peripheral blood and 30-day mortality.

Detailed Description

STUDY GOALS AND OBJECTIVES:

1. To obtain preliminary data regarding postoperative complications in subjects undergoing abdominal surgery and receiving remote limb ischemic or sham conditioning.

2. To test whether remote limb ischemic conditioning (RIC) decreases systemic inflammatory response in patients undergoing major abdominal surgery.

HYPOTHESiS:

The central hypothesis of the research is that pre- and post-operative RIC in patients undergoing major abdominal surgery would decrease the systemic inflammatory response to major abdominal surgery and decrease postoperative complications.

STUDY DESIGN:

A prospective, randomized, double - masked clinical trial of RIC will be conducted in adult patients undergoing major abdominal surgery at University Hospital in Newark, NJ. Participants will be randomized into two groups: RIC and No RIC. RIC will be induced at three time points - the first after anesthesia induction but before commencement of surgery, and the second and the third on post-operative days 1 and 2, respectively. The RIC intervention consists of 5 minutes of inflation of a pneumatic tourniquet placed mid-thigh followed by 5 minutes of deflation, repeated for 3 cycles. The pressure used will be 250 mmHg for the pre-operative intervention. Subsequent tourniquet pressures will be 50 mmHg above the patient's systolic blood pressure. The No RIC group will receive a sham intervention at all the same time points. The thigh tourniquet will be inflated to only 20 mmHg. A Doppler probe will be used to assess pedal arterial flow in both groups. Blood samples will be collected at baseline, 1hr after skin closure, and 1hr after interventions 2 and 3.

STUDY POPULATION:

Adults (\> 18 years of age) of both sexes scheduled for elective major abdominal surgery at University Hospital will be considered for inclusion. Major abdominal surgery is defined as peritoneal, retroperitoneal and pelvic surgery expected to last \>/= 120 minutes (from incision to closure) with an expected hospital stay \>/= 2 days. A list of surgeries considered for inclusion is included as Appendix A. Additional operations will be considered for inclusion if the study team and primary surgical team both agree that the procedure is a major abdominal surgery and that the duration of surgery is likely to be \> 2 hours.

RISKS AND BENEFITS

1. Risks to Subjects During inflation of the tourniquet in awake patients (post-op), there is a risk of pain secondary to tourniquet inflation. The investigators believe this risk is small, and if it occurs, the patient will have the option to discontinue the intervention.

There is a theoretical risk of injury to the limb receiving the RIC stimulus. However, such occurrences have not been reported to date in other clinical studies.

During collection of blood samples, there is a theoretical risk of bleeding from the venipuncture site; however this risk is no greater than routine blood draw. The amount of blood drawn for study purposes will be small (less than 50 mL total anticipated).

2. Benefits to Subjects The anticipated benefit to subjects is fewer complications after major abdominal surgery. However, no such benefit may accrue. In addition, the study is expected to provide valuable information regarding how RIC might modulate stress response to major surgery.

Study Timeline

• Study First Submitted: 2017-07-25
• Study First Submitted QC: 2017-07-28
• Study First Posted: 2017-07-31
• Study Start: 2017-10-08
• Status Verified: 2019-02
• Last Update Submitted: 2019-02-22
• Last Update Posted: 2019-02-25
• Primary Completion: 2019-06-15
• Study Completion: 2020-06-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Adults (> 18 years of age)
2. Both genders
3. Undergoing major abdominal surgery as above
4. Elective surgeries
5. Both outpatients and in-hospital patients
6. Post-op length of stay expected to be at least 2 days by the primary surgical service

Exclusion Criteria

1. Subjects with lower extremity paralysis

2. Lower extremity amputees

3. Known, documented peripheral arterial disease

4. Body mass index > 45

5. Pregnancy

6. Trauma patients

7. Organ transplant recipients

8. Prior major surgery during current hospitalization (for instance, a patient undergoing re-laparotomy for a complication from a previous procedure)

9. Patient taking sulfonylureas or nitrates prior to or during admission (listed in Appendix B)

   a. These subjects are excluded because sulfonylureas are shown to abrogate the RIC effect whereas nitrates are shown to mimic the RIC effect in animal models.

10. Non-elective surgeries (urgent or emergent surgeries)

11. General surgical procedures with no planned intra-abdominal component

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
No Remote Ischemic Conditioning	No Remote ischemic conditioning	The No RIC group will receive a sham intervention at all the same time points. The thigh tourniquet will be inflated to only 20 mmHg (to mask the intervention from the subject).
Remote Ischemic Conditioning	Remote ischemic conditioning	The RIC intervention consists of 5 minutes of inflation of a pneumatic tourniquet placed mid-thigh followed by 5 minutes of deflation, repeated for 3 cycles. The pressure used will be 250 mmHg for the pre-operative intervention. Subsequent tourniquet pressures will be 50 mmHg above the patient's systolic blood pressure.

Primary Outcome Measures

Name	Time	Method
Comprehensive Complication Index	30 days after surgery	The CCI, a validated and scaled score of all surgical complications (range 0 \[no complications\] to 100 \[death\]) will be computed for each subject using the publically available website, http://www.assessurgery.com/.

Secondary Outcome Measures

Name	Time	Method
30-day mortality	Up to 30 days	Proportions of patients dying within 30 days after surgery
Plasma acute phase reactant proteins (CRP, alpha-1- acid glycoprotein, FGN, and haptoglobin)	Up to 3 days	Measured at baseline, an hour after skin closure, completion of second and third research intervention
Hospital days	Up to 30 days	Number of days to discharge from the hospital after surgery
Peripheral blood leukocyte gene expression profiles determined by RNA sequencing.	Up to 3 days	Measured at baseline, an hour after skin closure, completion of second and third research intervention
Completion all three interventions	Up to 3 days	Proportions of subjects completing all three research interventions
Plasma complement levels (C2, C4b, C5, C5a, and C5b-9)	Up to 3 days	Measured at baseline, an hour after skin closure, completion of second and third research intervention
Plasma cytokines levels (TNF-a, IL - 1, 6, 8 and 10)	Up to 3 days	Plasma cytokine levels at baseline, an hour after skin closure, completion of second and third research intervention

Trial Locations

Locations (1)

University Hospital; 🇺🇸 Newark, New Jersey, United States